May 28 (Reuters) - Use of Pfizer Inc's (PFE.N) COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can recur after people complete a course of the drug, and that they should then isolate a second time.
That compares with 362 new cases a day earlier - 96 symptomatic and 266 asymptomatic infections, which China counts separately. First steps in reforming global health emergency rules adopted at WHO meeting - U.S Countries around the world on Saturday adopted an initial U.S.-led reform of the rules around disease outbreaks, known as the International Health Regulations (IHR), the United States said.
The Fiji Times » U S doctors reconsider Pfizer s Paxlovid for lower-risk COVID patients fijitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fijitimes.com Daily Mail and Mail on Sunday newspapers.
By Deena Beasley (Reuters) - Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-.
So far 13 people have been arrested for building violations, they said. 'Message to the world' - Lithuanians club together to buy drone for Ukraine Hundreds of Lithuanians are clubbing together to buy an advanced military drone for Ukraine in its war against Russia, in a show of solidarity with a fellow country formerly under Moscow's rule.